Condition
Antineoplastics Toxicity clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Antineoplastics Toxicity clinical trials that are recruiting, at sites in 6 countries (most in Spain (2), Australia (1), Canada (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
Stopping heart failure medications in cancer survivors with heart dysfunction
This study is testing if cancer survivors with improved heart function can safely stop taking their heart failure medications to see if it reduces their pill burden and side effects.
-
Investigating kidney damage from immune checkpoint inhibitors
This study is testing how immune checkpoint inhibitors used in cancer treatment might affect kidney health in patients starting immunotherapy, to find ways to spot problems early.
Related topics
Quick answers
How many Antineoplastics Toxicity clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Spain (2 trials), Australia (1 trial), Canada (1 trial), Poland (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.